OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanism of Inhibition of the Reproduction of SARS-CoV-2 and Ebola Viruses by Remdesivir
Jimin Wang, Krystle Reiss, Yuanjun Shi, et al.
Biochemistry (2021) Vol. 60, Iss. 24, pp. 1869-1875
Closed Access | Times Cited: 15

Showing 15 citing articles:

Synergism between remdesivir and ribavirin leads to SARS‐CoV‐2 extinction in cell culture
Carlos García‐Crespo, Ana Isabel de Ávila, Isabel Gallego, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 15, pp. 2636-2654
Open Access | Times Cited: 8

Efficient incorporation and template-dependent polymerase inhibition are major determinants for the broad-spectrum antiviral activity of remdesivir
Calvin J. Gordon, Hery W. Lee, Egor P. Tchesnokov, et al.
Journal of Biological Chemistry (2021) Vol. 298, Iss. 2, pp. 101529-101529
Open Access | Times Cited: 31

Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns
Hazem Mslati, Francesco Gentile, Carl F. Perez, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 8, pp. 3771-3788
Closed Access | Times Cited: 22

Remdesivir: Quo vadis?
Erik De Clercq
Biochemical Pharmacology (2021) Vol. 193, pp. 114800-114800
Open Access | Times Cited: 19

Structural Insights into Binding of Remdesivir Triphosphate within the Replication–Transcription Complex of SARS-CoV-2
Jimin Wang, Yuanjun Shi, Krystle Reiss, et al.
Biochemistry (2022) Vol. 61, Iss. 18, pp. 1966-1973
Closed Access | Times Cited: 14

Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics
L Tóth, Kateřina Krejčová, Milan Dejmek, et al.
Beilstein Journal of Organic Chemistry (2024) Vol. 20, pp. 1029-1036
Open Access | Times Cited: 2

Insights into the structural stability of major groove RNA triplexes by WAXS-guided MD simulations
Yen-Lin Chen, Weiwei He, Serdal Kırmızıaltın, et al.
Cell Reports Physical Science (2022) Vol. 3, Iss. 7, pp. 100971-100971
Open Access | Times Cited: 10

Therapeutics development for Ebola virus disease: A recent scenario
Chiranjib Chakraborty
Current Opinion in Pharmacology (2021) Vol. 60, pp. 208-215
Closed Access | Times Cited: 14

Translocation pause of remdesivir-containing primer/template RNA duplex within SARS-CoV-2’s RNA polymerase complexes
Yuanjun Shi, Jimin Wang, Víctor S. Batista
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 3

Identification and evaluation of antiviral activity of novel compounds targeting SARS-CoV-2 virus by enzymatic and antiviral assays, and computational analysis
Ivana Nemčovičová, Katarína Lopušná, Iveta Štibrániová, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access

Targeting RdRp of SARS-CoV-2 with De Novo Molecule Generation
Amal Vijay, Venkata Sai Sreyas Adury, Arnab Mukherjee
ACS Applied Bio Materials (2023) Vol. 7, Iss. 2, pp. 609-616
Open Access | Times Cited: 1

Studies on the synthesis of 1′-CN-triazolyl-C-ribosides
Nina Božinović, Viviane Marques de Aguiar, Angélique Ferry, et al.
Organic & Biomolecular Chemistry (2022) Vol. 20, Iss. 36, pp. 7261-7269
Closed Access | Times Cited: 2

Remdesivir: Mechanism of Metabolic Conversion from Prodrug to Drug
Saumya Kapoor, Gurudutt Dubey, Samima Khatun, et al.
Current Drug Metabolism (2021) Vol. 23, Iss. 1, pp. 73-81
Closed Access | Times Cited: 2

Page 1

Scroll to top